Clinical Trial Update: ALICIA (Acalabrutinib in CLL Therapy)

View source ↗

Summary

Clinical trial update for the ALICIA study evaluating acalabrutinib in chronic lymphocytic leukemia; the study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CALQUENCE (ACALABRUTINIB)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Lymphocytic Leukemia | Status: ACTIVE_NOT_RECRUITING